IL17A and rheumatoid arthritis: Ex vivo experiments showed that SFN indeed enhanced the ROS levels in lymphocytes within whole blood of RA patients and inhibited production of the pro-inflammatory cytokines IL-17A, IL-17F, and IL-22.